Eir Ventures’ Investment in ISD Immunotech

Moalem Weitemeyer assisted Eir Ventures in the transaction.SD Immunotech ApS (“ISD”), a biotech company developing new anti-inflammatory treatments, announced that Eir Ventures have completed an investment…

This content is for Standard 1 Year members only.
Login Join Now
Federica Tiefenthaler

Author: Federica Tiefenthaler

This content is for Standard 1 Year members only.
Login Join Now